Hemodynamic consequences of prostaglandin E2 activation of the renin-angiotensin system in heart failure.
D015232:Dinoprostone / Q000031:analogs & derivatives*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*; D011652:Pulmonary Circulation / Q000187:drug effects; D012084:Renin-Angiotensin System / Q000187:drug effects*; D014661:Vasoconstriction / Q000187:drug effects
D011459:Prostaglandins E, Synthetic; D015232:Dinoprostone; C034232:viprostol